-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C71tiZPIPr0h47msP6r+F2qsnIAgYPh2KLFExcWWDmQg4y9trsw7/tEPEf8QyjYa U75IU89mTSR00KZ4Rc1V0Q== 0000950135-97-001880.txt : 19970417 0000950135-97-001880.hdr.sgml : 19970417 ACCESSION NUMBER: 0000950135-97-001880 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970413 ITEM INFORMATION: Other events FILED AS OF DATE: 19970416 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDITRUST CENTRAL INDEX KEY: 0000774350 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 046532031 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09582 FILM NUMBER: 97581928 BUSINESS ADDRESS: STREET 1: 197 FIRST AVE CITY: NEEDHAM STATE: MA ZIP: 02194 BUSINESS PHONE: 6174336000 MAIL ADDRESS: STREET 1: 197 FIRST AVENUE CITY: NEEDHAM STATE: MA ZIP: 02194 8-K 1 MEDITRUST 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): APRIL 13, 1997 MEDITRUST -------------------------------- (Exact name of registrant as specified in its charter) Commission file number 1-09582 MASSACHUSETTS 04-6532031 (State or other jurisdiction of (I.R.S. Employer or incorporation or organization) Identification No.) 197 FIRST AVENUE, NEEDHAM, MASSACHUSETTS 02194-9127 ----------------------------------------- ---------- (Address of principal executive offices) (Zip Code) (617) 433-6000 ---------------------- (Registrant's telephone number, including area code) 2 ITEM 5. OTHER EVENTS. On April 13, 1997, Meditrust and its wholly-owned subsidiary, Meditrust Acquisition Corporation IV (together, "Meditrust") entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with Santa Anita Realty Enterprises, Inc. and Santa Anita Operating Company (together, "Santa Anita"). When the transaction is consummated, Meditrust will be merged into Santa Anita, and shareholders of Meditrust will receive 1.2016 paired common shares of Santa Anita for each share of Meditrust they own in a tax-free exchange of shares. Based on the closing price of Meditrust on April 11, 1997 of $37.25 per share, the transaction will have an initial value to the shareholders of Santa Anita of approximately $383 million, or $31.00 per paired common share. Upon completion of the merger, the surviving corporations will be called Meditrust Corporation and Meditrust Operating Company. Meditrust has agreed to buy approximately 1.2 million paired common shares of Santa Anita at $31.00 per paired common share. In addition, Santa Anita has agreed to sell to one or more independent parties designated by Meditrust approximately 1.0 million Santa Anita paired common shares at a price of $31.00 per paired common share. As of March 31, 1997, there were approximately 61.5 million shares of beneficial interest of Meditrust outstanding and there were approximately 11.5 million paired shares of common stock and approximately 867,000 paired shares of preferred stock of Santa Anita outstanding. The Merger Agreement also provides that, if requested by Santa Anita, Meditrust will make available to Santa Anita $100 million (less the purchase price of the 1.2 million paired common shares acquired by Meditrust) to be used by Santa Anita for a cash self tender or cash election to its shareholders at a price of $31.00 per paired common share. The transaction, which has been approved unanimously by the Board of Trustees of Meditrust and the Boards of Directors of Santa Anita, is subject to regulatory approvals and approvals of the shareholders of both Meditrust and Santa Anita. The merger is not subject to any financing conditions. The parties intend to file proxy materials for the proposed transaction as soon as possible. The transaction is expected to close in the fall of 1997. 2 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDITRUST April 16, 1997 By: /s/ Michael S. Benjamin -------------------------------------------- Michael S. Benjamin Senior Vice President and Secretary -----END PRIVACY-ENHANCED MESSAGE-----